title: WHO urges the phasing out of artemisinin based monotherapy for malaria to reduce resistance.
authors.forename: Weiyuan
authors.initials: W
authors.lastname: Cui
mesh_terms: D000962:Antimalarials / Q000627:therapeutic use*; D037621:Artemisinins / Q000627:therapeutic use*; D004351:Drug Resistance; D006801:Humans; D008288:Malaria / Q000188:drug therapy* / Q000517:prevention & control; D014944:World Health Organization
chemical_list: D000962:Antimalarials; D037621:Artemisinins; C031327:artemisinin